Methyldopa can potentiate the effects of anticoagulants, risking increased bleeding. Patients should regularly monitor their INR and adjust anticoagulant doses as necessary.

Methyldopa may enhance the blood-thinning effect of anticoagulants, increasing hemorrhage risk. Close monitoring of blood clotting parameters and dose adjustments are crucial.

When methyldopa is used with anticoagulants, bleeding risks are heightened. It’s vital for caregivers to frequently check coagulation levels and adapt anticoagulant dosage accordingly.